European Medicines Agency to relocate to Amsterdam
The European Medicines Agency, which has been based in London since its establishment in 1995, will move to Amsterdam, the Netherlands. The need to relocate is a consequence of the U.K.’s withdrawal from the European Union.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
Blog
European Medicines Agency publishes Brexit guidance for pharma companies
The European Medicines Agency has published additional guidance for pharmaceutical companies to help them prepare for the United Kingdom’s withdrawal from the European Union.
-
PremiumDelayed UK antitrust case underscores compliance, reputational risks
Antitrust infringement cases in the United Kingdom can run on for years, but there’s a question whether issuing fines that are dwarfed by the revenues of those organisations involved is a worthy deterrent—particularly if they are imposed over a decade after the misconduct ended. It’s also debatable whether the first ...
-
OpinionOur rapidly changing world still needs thoughtful compliance, now more than ever
Sometimes, it feels like the only thing that’s certain is that tomorrow will be different from today. For an industry that’s focused on rules, regulations, and ethics, that lack of consistency can seem overwhelming. That’s why the next few days will matter so much.